top
Search terms
Results 41 - 50 of 103 - ordered by :
Pages: 1 ... 2 3 4 5 6 7 8 ... 11
Ehjcvp

Abstract Cardiovascular disease is the leading cause of morbidity and mortality among patients with diabetes, underscoring the importance of choosing anti-diabetic drugs that do not increase ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, R. Kumar, D. M. Kerins, T. Walther

Date : 01/01/2016 Item size : 517106 bytes
Ehjcvp

[...]year of a journal Since they are selected due to their known knowledge and good reputation, my friends expected that their fees would be sky high. Laura Fortuna and co-workers from USA ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Stefan Agewall

Date : 01/01/2016 Item size : 108210 bytes
Ehjcvp

ApoA-I Milano (apoA-IM) is a natural variant of human apoA-I identified in individuals in northern Italy, which results from the replacement of arginine by cysteine at position 173 of the apoA-I ...

European Heart Journal - Cardiovascular Pharmacotherapy, INVITED EDITORIAL, Antonio J. Vallejo-Vaz, Kausik K. Ray

Date : 01/01/2016 Item size : 167390 bytes
Ehjcvp

Unfortunately, gastrointestinal bleeding in patients after acute coronary syndrome portends poor prognosis and is independently associated with increased risk for adverse cardiovascular events and ...

European Heart Journal - Cardiovascular Pharmacotherapy, INVITED EDITORIAL, Muthiah Vaduganathan, Deepak L. Bhatt

Date : 01/01/2016 Item size : 163944 bytes
Ehjcvp

A single infusion of MDCO-216 (ApoA-1 Milano/POPC) increases ABCA1-mediated cholesterol efflux and pre-beta 1 HDL in healthy volunteers and patients with stable coronary artery disease Methods and ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, D.G. Kallend, J.A.A. Reijers, S.E. Bellibas, A. Bobillier, H. Kempen, J. Burggraaf, M. Moerland, P.L.J. Wijngaard

Date : 01/01/2016
Ehjcvp

Differences between sexes and during pubertal development suggest an influence of sex hormones on plasma PCSK9 concentrations There were no sex differences in PCSK9 concentrations in young adults, ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, Eliano P. Navarese, Michalina Kołodziejczak, Dimitrios Dimitroulis, Georg Wolff, Hans L. Busch, Fiorella Devito, Alessandro ...

Date : 01/01/2016
Ehjcvp

(1995) Prospective, randomized, placebo-controlled trial 194 patients Emergency department Adults patients w/ OHCA of cardiac aetiology Adrenaline 10 mg Saline placebo Not reported iv Immediate ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, Andreas Lundin, Therese Djärv, Johan Engdahl, Jacob Hollenberg, Per Nordberg, Annika Ravn-Fischer, Mattias Ringh, Susanne Rysz, ...

Date : 01/01/2016
Ehjcvp

Mechanistically, this separates the drug from conventional anti-anginal therapies, namely beta-adrenergic antagonists, calcium channel blockers, and nitrates. [...]a haemodynamically neutral ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEW, Cian P. McCarthy, Kieran V. Mullins, David M. Kerins

Date : 09/12/2015
Ehjcvp

Hypertension constitutes a major risk factor for cardiovascular mortality, myocardial infarction, heart failure, stroke, atrial fibrillation, and peripheral arterial disease, with one billion people ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEW, Vasiliki Katsi, Georgios Skalis, Antonis N. Pavlidis, Thomas Makris, Petros Nihoyannopoulos, Dimitris Tousoulis, Ioannis Kallikazaros

Date : 01/10/2015 Item size : 268677 bytes
Ehjcvp

Despite treatments for secondary prevention, patients with prior myocardial infarction (MI) remain at high risk for recurrent thrombotic events.1 The addition of a P2Y12 receptor antagonist to ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIAL, Giulia Magnani, Marc P. Bonaca, Marc S. Sabatine

Date : 01/10/2015 Item size : 188203 bytes